Margaret Ashton‐Key

2.5k total citations
44 papers, 1.3k citations indexed

About

Margaret Ashton‐Key is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Margaret Ashton‐Key has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Margaret Ashton‐Key's work include Lymphoma Diagnosis and Treatment (19 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Margaret Ashton‐Key is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Margaret Ashton‐Key collaborates with scholars based in United Kingdom, Taiwan and Switzerland. Margaret Ashton‐Key's co-authors include P G Isaacson, Ming‐Qing Du, P G Isaacson, Tim C. Diss, TC Diss, Kathleen N. Potter, Lingxiao Pan, C. Ian Mockridge, Stephen A. Beers and Peter Johnson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Margaret Ashton‐Key

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Ashton‐Key United Kingdom 21 473 451 427 303 289 44 1.3k
Michael Vesely Austria 16 536 1.1× 323 0.7× 303 0.7× 233 0.8× 202 0.7× 31 1.2k
António E. Pinto Portugal 24 506 1.1× 742 1.6× 283 0.7× 320 1.1× 707 2.4× 74 2.4k
Michihide Tokuhira Japan 22 394 0.8× 450 1.0× 220 0.5× 327 1.1× 231 0.8× 80 1.4k
Friederike Kreisel United States 18 363 0.8× 384 0.9× 362 0.8× 206 0.7× 337 1.2× 61 1.4k
Jun‐ichi Tamaru Japan 21 862 1.8× 771 1.7× 224 0.5× 267 0.9× 205 0.7× 108 1.5k
Ph. M. Kluin Netherlands 21 647 1.4× 445 1.0× 246 0.6× 204 0.7× 334 1.2× 45 1.6k
Rogers C. Griffith United States 17 376 0.8× 445 1.0× 245 0.6× 268 0.9× 390 1.3× 35 1.5k
Huaizheng Peng United Kingdom 13 757 1.6× 396 0.9× 411 1.0× 326 1.1× 265 0.9× 21 1.3k
Hans‐Heinrich Wacker Germany 18 782 1.7× 541 1.2× 499 1.2× 325 1.1× 163 0.6× 28 1.3k
Ayoma D. Attygalle United Kingdom 22 1.3k 2.7× 885 2.0× 469 1.1× 324 1.1× 169 0.6× 83 2.0k

Countries citing papers authored by Margaret Ashton‐Key

Since Specialization
Citations

This map shows the geographic impact of Margaret Ashton‐Key's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Ashton‐Key with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Ashton‐Key more than expected).

Fields of papers citing papers by Margaret Ashton‐Key

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Ashton‐Key. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Ashton‐Key. The network helps show where Margaret Ashton‐Key may publish in the future.

Co-authorship network of co-authors of Margaret Ashton‐Key

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Ashton‐Key. A scholar is included among the top collaborators of Margaret Ashton‐Key based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Ashton‐Key. Margaret Ashton‐Key is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, H.W., Margaret Ashton‐Key, Benjamin H. Stevens, et al.. (2024). The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications. SHILAP Revista de lepidopterología. 5(4). 877–901. 2 indexed citations
2.
Foxall, Russell B., Kerry L. Cox, Robert Oldham, et al.. (2024). CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis. PubMed. 5(1). ltaf029–ltaf029.
3.
4.
Birts, Charles N., Constantinos Savva, Margaret Ashton‐Key, et al.. (2022). Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma. Scientific Reports. 12(1). 7802–7802. 13 indexed citations
5.
Machado, Maria do Céu, Margaret Ashton‐Key, Serena Chee, et al.. (2021). Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment. Neuroendocrinology. 112(4). 370–383. 11 indexed citations
6.
Easton, Alistair, Tatyana Inzhelevskaya, Sonya James, et al.. (2020). Immune characterization of pre-clinical murine models of neuroblastoma. Scientific Reports. 10(1). 16695–16695. 27 indexed citations
7.
Roghanian, Ali, Guangan Hu, Christophe Fraser, et al.. (2019). Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression. Cancer Immunology Research. 7(11). 1876–1890. 29 indexed citations
8.
Moody, Sarah, Joe Sneath Thompson, Shih‐Sung Chuang, et al.. (2018). Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica. 103(8). 1329–1336. 42 indexed citations
9.
Ashton‐Key, Margaret, Jonathan C. Strefford, Freda K. Stevenson, et al.. (2017). Regulation and Impact of BCR Induced Autophagy in Chronic Lymphocytic Leukemia. Blood. 130. 1717–1717. 1 indexed citations
10.
Papadakis, Emmanouil, Alison Yeomans, Stephen A. Beers, et al.. (2016). A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells. Oncotarget. 7(14). 18851–18864. 11 indexed citations
11.
Chowdhury, Ferdousi, et al.. (2015). PD-L1 and CD8+PD1+ lymphocytes exist as targets in the pediatric tumor microenvironment for immunomodulatory therapy. OncoImmunology. 4(10). e1029701–e1029701. 50 indexed citations
12.
Ashton‐Key, Margaret, Sergio Cogliatti, Susanne Crowe, et al.. (2013). Expression of inhibitory Fc receptor (FcγRIIB) is a marker of poor response to rituximab monotherapy in follicular lymphoma. The Lancet. 381. S63–S63. 4 indexed citations
13.
Brierly, R.D., et al.. (2000). Evaluation of fine‐needle aspiration cytology for renal masses. British Journal of Urology. 85(1). 14–18. 48 indexed citations
14.
Mercieca, Jane, et al.. (1998). Aggressive NK Cell Lymphoma Preceded by a Ten Year History of Neutropenia Associated with Large Granular Lymphocyte Lymphocytosis. Leukemia & lymphoma. 31(3-4). 417–421. 5 indexed citations
15.
Ashton‐Key, Margaret, et al.. (1997). The Value of the Polymerase Chain Reaction in the Diagnosis of Cutaneous T-Cell Infiltrates. The American Journal of Surgical Pathology. 21(7). 743–747. 52 indexed citations
16.
Ashton‐Key, Margaret, Gerard Cowley, & Mark E. Smith. (1996). Cadherins in reactive lymph nodes and lymphomas: high expression in anaplastic large cell lymphomas. Histopathology. 28(1). 55–59. 13 indexed citations
17.
Miller, KD, et al.. (1995). Antigen Unmasking in Formalin-Fixed Routinely Processed Paraffin Wax-Embedded Sections by Pressure Cooking. Advances in Anatomic Pathology. 2(1). 60–64. 67 indexed citations
18.
Ashton‐Key, Margaret, et al.. (1995). Follicular Hodgkin's disease.. PubMed. 19(11). 1294–9. 44 indexed citations
19.
Ashton‐Key, Margaret, TC Diss, P G Isaacson, & Mark E. Smith. (1995). A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma. Histopathology. 27(6). 501–508. 31 indexed citations
20.
Cox, Graham J., et al.. (1993). Pilomatrixoma of the external auditory meatus. The Journal of Laryngology & Otology. 107(4). 333–334. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Vesely Breakdown of academic impact, for papers by António E. Pinto Breakdown of academic impact, for papers by Michihide Tokuhira Breakdown of academic impact, for papers by Friederike Kreisel Breakdown of academic impact, for papers by Jun‐ichi Tamaru Breakdown of academic impact, for papers by Ph. M. Kluin Breakdown of academic impact, for papers by Rogers C. Griffith Breakdown of academic impact, for papers by Huaizheng Peng Breakdown of academic impact, for papers by Hans‐Heinrich Wacker Breakdown of academic impact, for papers by Ayoma D. Attygalle
Rankless by CCL
2026